source
- Eli Lilly signals interest in researching and improving psychedelic ibogaine, says neuroscience chiefAt a recent psychedelics conference, Eli Lilly’s neuroscience president Carole Ho announced the company’s interest in studying ibogaine. Ho said Lilly aims to improve the drug’s safety and efficac…
- Study shows clinicians increasingly turn to AI for medical queries despite limited evidence of impactNew research examined usage data from OpenEvidence, an AI search platform, to track how clinicians use AI to answer medical questions. Findings show a rapid increase in the frequency of AI queries…